HS-10370

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HS-10370, covering 2024-09-19 to 2025-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors [Phase 1]

See pricing